Pharmaceutical
Experimental peptides are gaining attention across the United States as consumers seek new treatments for weight loss, recovery and longevity. However, limited human clinical evidence and changing FDA regulations present difficult questions for healthcare providers. Recent reporting and physician surveys reveal a growing divide between consumer demand and established medical standards.
AbbVie has completed its $10.9 billion acquisition of Apogee Therapeutics, gaining clinical-stage drugs for atopic dermatitis, asthma and other inflammatory diseases. The deal strengthens AbbVie’s immunology pipeline but is expected to dilute earnings until the next decade.
The obesity drug market is entering a new phase as pharmaceutical companies race to develop oral therapies, combination treatments and next-generation medicines. With forecasts pointing to a $100 billion annual market, competition is shifting from two dominant players to a much broader field of innovators.
Roberta Loomar challenges herself by taking legal leadership of a company just this side of “startup”
Garlan Adams is a chief legal officer with a patient-centered mission
Matt Mitchell, Chief Pharmacy Officer of Select Health and Scripius, is pushing pharmacy services beyond traditional roles
Check out ten problem-solving, collaborative healthcare executives to watch across hospital systems, pharmaceutical organizations, and medical schools
Holly Smith details programs that ensure UToledo Health patients get the care they need when they need it
We’re showcasing six pharmacy executives driving innovation and impact at their organizations
This Women’s History Month, we’re highlighting six impressive women in healthcare who are making an impact at their organizations
Louis Sokos has spent over a decade building new business lines, such as home infusions, to benefit patients at WVU Medicine
Elie Bahou of Providence is a veteran of the pharmacy space whose heart, it turns out, is in sales
